Research News

World Ovarian Cancer Coalition Releases Every Woman Study Report

(October 25, 2018) Through a series of surveys, interviews, and literature reviews the World Ovarian Cancer Coalition produced a report that detailed their findings and recommendations…

Read on

Maintenance olaparib Improves Progression-Free Survival in Phase III Clinical Trial

(October 23, 2018) Olaparib, or Lynparza, was shown to increase progression-free survival (PFS) by almost three years in an ongoing trial known as SOLO-1…

Read on

OCRA Research Shows How Cancer Cells Negatively Impact the Communication between the Ovary and Fallopian Tube

(October 22, 2018) A team at the University of Illinois at Chicago, including OCRA grantee Matthew Dean, PhD, recently discovered the role that cancer cells have on their immediate environment. The research was funded in part by OCRA…

Read on

Study Looks at Long-term Survival Trends in Ovarian Cancer

(October 19, 2018) A retroactive study using SEER, or Surveillance, Epidemiology, and End Results, looked at the trends in ovarian cancer from 1983 to 2012. In almost 3 decades, the incidence of ovarian cancer per 100,000 fell from 13.7 to 10…

Read on

Kunle Odunsi, MD, PhD, Elected to National Academy of Medicine

(October 18, 2018) Longtime OCRA Scientific Advisory Committee member and former grantee Kunle Odunsi, MD, PhD, has been elected to the National Academy of Medicine—a distinguished lifetime designation that is considered one of the highest honors…

Read on

OCRA Funded Research Reveals Immune Suppression in Ovarian Cancer

(October 15, 2018) This month in Nature, researchers from Weill Cornell published a study that helps to explain why the body’s natural immune response struggles to fight back against ovarian cancer…

Read on

Certain Kinds of Contemporary Birth Control Pills Shown to Reduce Ovarian Cancer Risk

(October 11, 2018) The BMJ recently published a study from Denmark about the effect that newer birth control pills have on ovarian cancer risk…

Read on

Baby Aspirin Associated with Lower Risk of Ovarian Cancer

(October 9, 2018) A study, published in JAMA Oncology, followed about 200,000 women over the course of 25 years in order to track their use of analgesics…

Read on

OCRA Funded Study Increased Genetic Counseling Referrals for Epithelial Ovarian Cancer Patients

(October 2, 2018) A study by the Mayo Clinic earlier this year aimed to increase the amount of genetic counseling referrals to epithelial ovarian cancer patients by supplying patients with a Genetics Referral Toolkit…

Read on

OCRFA Funded Research Identifies Biomarker Linked to HGSOC Treatment and Survival Outcomes

(September 21, 2018) In an international collaboration funded in part by OCRFA, published recently in Cell, researchers used proteomics, the large-scale study of proteins, to identify an important indicator for treatment and disease-free survival in…

Read on

Big Strides Made in Identifying More BRCA1 Mutations

(September 19, 2018) Researchers at the University of Washington recently made a breakthrough in identifying and confirming variants of the BRCA1 mutation, a gene mutation that increases a woman’s risk of breast and ovarian cancers…

Read on

Exploring the Importance of Glycogen in Cancer Metastasis

(September 14, 2018) A study published in Cell Metabolism explores the use of glycogen by ovarian cancer tumor cells, specifically in an area where metastasis happens quickly, the omentum…

Read on